Skip to main content
. 2021 Mar 27;9(2):71. doi: 10.3390/pharmacy9020071

Table 4.

Risk-of-bias Assessment [10,13,19,20,21,29,30].

Randomization Process Confounding Factors Selection of Participants Classification of Interventions Deviations from Intended Interventions Missing Data Measurement of Outcomes Selection of Reported Result Overall Bias
ROB2 1
Ito et al. RCT (2001) Low risk N/A N/A N/A Low risk Low risk Low risk Low risk Low risk
Meston et al. RCT (2002) Low risk N/A N/A N/A Low risk Low risk Low risk Low risk Low risk
Ito et al. RCT (2006) Low risk N/A N/A N/A Low risk Low risk Low risk Low risk Low risk
Bottari et al. RCT (2012) Low risk N/A N/A N/A Some concerns Low risk Low risk Low risk Some concerns
Stanislavov et al. RCT (2014) Some concerns N/A N/A N/A Low risk Low risk Low risk Low risk Some concerns
ROBINS-I 2
Bottari et al. NRCT (2013) N/A Serious concerns Low risk Moderate risk Low risk Some concerns Serious concerns Low Risk Serious risk
Cesarone et al. NRCT (2019) N/A Serious concerns Low risk Moderate risk Low risk Low risk Serious concerns Low Risk Serious risk

Abbreviations: NRCT: nonrandomized controlled trial, RCT: randomized controlled trial. 1 Confounding factors, Selection of participants and classification of interventions are not included in the ROB2 tool. 2 ROBINS-I does not account for randomization as these studies are nonrandomized controlled trials.